Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/7838Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Stathopoulos, G. P. | en |
| dc.contributor.author | Armakolas, A. | en |
| dc.contributor.author | Tranga, T. | en |
| dc.contributor.author | Marinou, H. | en |
| dc.contributor.author | Stathopoulos, J. | en |
| dc.contributor.author | Chandrinou, H. | en |
| dc.date.accessioned | 2015-11-24T16:34:42Z | - |
| dc.date.available | 2015-11-24T16:34:42Z | - |
| dc.identifier.issn | 1791-2431 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/7838 | - |
| dc.rights | Default Licence | - |
| dc.subject | Carcinoma, Non-Small-Cell Lung/*metabolism/pathology | en |
| dc.subject | Granulocyte Colony-Stimulating Factor/*biosynthesis | en |
| dc.subject | Humans | en |
| dc.subject | Immunohistochemistry | en |
| dc.subject | Lung Neoplasms/*metabolism/pathology | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Prognosis | en |
| dc.subject | Reverse Transcriptase Polymerase Chain Reaction| | en |
| dc.title | Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.3892/or.2011.1226 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21431281 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιών | el |
| heal.publicationDate | 2011 | - |
| heal.abstract | Hematologic paraneoplastic alternations may not be very common, but they have been observed in a small number of patients. Granulocytosis has been described in several malignancies and its common mechanism may be associated with granulocyte colony-stimulating factor (G-CSF) production by the tumor. High neutrophilia (150,000-240,000 white blood cell count) observed in two patients with non-small cell lung cancer led us to run the present trial. The purpose of this study was to compare the white blood cell counts and the G-CSF plasma levels of the patients and classify the results into groups, as well as to determine the survival rates of the patients in each of the groups. The histological specimens and plasma of two patients as well as the plasma of another 87 patients with several malignancies, were examined. The plasma G-CSF levels were determined using a quantitative sandwich immunoassay technique (Quantikine; RySD systems) according to the manufacturer's instructions and all samples were tested in triplicate. It was found that 12 patients had a white blood cell count increased beyond normal as well as a high G-CSF plasma level and the survival of these patients was shorter as compared to the rest of the patients. We assume that these findings may indicate that increased G-CSF levels may function as a biomarker of survival. | en |
| heal.journalName | Oncol Rep | en |
| heal.journalType | peer reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| tranga-2011-Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer.pdf | 315.36 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
